June 19, 2020 / 1:12 PM / 2 months ago

BRIEF-Sanofi Announces Positive Efficacy And Safety Data For Fitusiran From Phase 2 Study

June 19 (Reuters) - Sanofi SA:

* SANOFI ANNOUNCES POSITIVE LONG-TERM EFFICACY AND SAFETY DATA FOR FITUSIRAN FROM INTERIM ANALYSIS OF PHASE 2 EXTENSION STUDY IN PEOPLE WITH HEMOPHILIA A AND B, WITH OR WITHOUT INHIBITORS

* WE CONTINUE TO INVESTIGATE CLINICAL PROFILE OF FITUSIRAN IN OUR PHASE 3 ATLAS PROGRAM WITH RESULTS EXPECTED IN FIRST HALF OF 2021 Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below